Andy Evans, Head of global SC planning, AstraZeneca about AstraZeneca's Lean SCM Journey

Andy Evans, Head of global SC planning, AstraZeneca
Andy Evans, Head of global SC planning, AstraZeneca

"Our Lean Supply Chain Visibility initiative reshaped our operations and supply chain management operating model with fundamental new global capabilities to realize end-to-end lean and agile supply chains and a step change in information systems."
Andy Evans, Head of global SC planning, AstraZeneca

AstraZeneca started its lean journey to respond to emerging cost pressure and higher market dynamics in managing global supply chains in the pharmaceutical industry. Following a clear lean vision for their entire supply chain organization, AstraZeneca established a demand-driven supply chain approach based upon lean planning methods, high end-to-end transparency, and strong process governance. The higher efficiency and responsiveness of their supply chain organization improved key figures such as working capital, lead-times, and asset utilization considerably. Furthermore, their lean supply chain strengthened their capability to provide highest customer service despite growing market uncertainties.

Learn more about Lean Supply Chain Planning, just visit www.leansupplychainplanning.com

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read